Followers | 2 |
Posts | 195 |
Boards Moderated | 0 |
Alias Born | 08/23/2006 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 19, 2007 10:16:29 AM
There is evidence that neuropeptide Y (NPY) is anticonvulsant and reduces neuronal cell death following excitotoxic insult through activation of the Y2 receptor. Various studies have shown that NPY expression is positively regulated by brain-derived neurotrophic factor (BDNF). We have previously reported that intermittent treatment of hippocampal slice cultures with ampakines (i.e., positive AMPA receptor modulators) increases BDNF expression and affords BDNF-dependent neuroprotection from an ischemic insult.
The effects of ampakines on multiple types of inspiratory (I) and expiratory (E) neurons within the preBötC and hypoglossal motoneurons are analyzed. Preliminary data show a marked increase in the drive potential and inward inspiratory synaptic current of inspiratory (I) neurons.
-------------------------------------------------------------
what language is that?? that's less comperhensible than the agreement the two teams of lawyers put together for cortex and uc.
-------------------------------------------------------------
-------------------------------------------------------------
-------------------------------------------------------------
and,"Once you skim through these 10 abstracts you will not sell a single share until this baby is bought out or hits 50."
-------------------------------------------------------------
that i understand, but life expentancy is only 76 for an american male, and i'm 60; 76 is not that far away.
but i have a plan to give cortex time to get to 50. i heard that in a certain part of japan the men live on average to 101, so when i'm 75 i'm going to move there.
but if cortex still hasn't reached 50 (i hope you meant dollars) by the time i'm 101, i'll sell my cortex and make Pre-arranged funeral plans.
fred
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:05:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 12:52:24 PM
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM